Global Biotech Stocks

Biogened

Market Cap: zł60.9m

Develops, produces, and distributes pharmaceutical products in Poland.

Longeveron

Market Cap: US$16.8m

A clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.

Phapros

Market Cap: Rp277.2b

Operates in the pharmaceutical industry in Indonesia.

GeoVax Labs

Market Cap: US$16.5m

A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.

Biosino Bio-Technology and Science Incorporation

Market Cap: HK$125.9m

Manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China.

Athira Pharma

Market Cap: US$16.1m

Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.

BioLineRx

Market Cap: ₪53.7m

A commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.

Tyche Industries

Market Cap: ₹1.4b

Manufactures and sells active pharmaceutical ingredients and intermediates in India and internationally.

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

Futura Medical

Market Cap: UK£11.8m

Research, develops, and commercializes pharmaceutical and healthcare products for sexual health.

NextCure

Market Cap: US$15.4m

A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.

Valbiotis

Market Cap: €12.9m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

Par Drugs and Chemicals

Market Cap: ₹1.3b

Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.

Lipocine

Market Cap: US$15.0m

A clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders.

Avecho Biotechnology

Market Cap: AU$22.2m

A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India.

ProBiotix Health

Market Cap: UK£10.7m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

OptiBiotix Health

Market Cap: UK£10.6m

A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.

BioVie

Market Cap: US$14.0m

A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States.

Nirman Agri Genetics

Market Cap: ₹1.2b

Operates as an agri-input company in India.

Gelteq

Market Cap: US$14.0m

Focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region.

Pharma-Bio Serv

Market Cap: US$13.8m

Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.

Alzinova

Market Cap: SEK 127.9m

A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

Chemomab Therapeutics

Market Cap: US$13.5m

A clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States.

Immuron

Market Cap: AU$20.4m

A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.

Mangalam Drugs & Organics

Market Cap: ₹1.2b

Together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India.

Vivesto

Market Cap: SEK 125.4m

Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.

Ayr Wellness

Market Cap: CA$18.1m

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.

Biosergen

Market Cap: SEK 123.0m

A biotech company, develops antifungal products.

Amwill Health Care

Market Cap: ₹1.2b

A derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India.

Phio Pharmaceuticals

Market Cap: US$12.8m

A a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States.

Polyrizon

Market Cap: US$12.7m

A biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.

Aptorum Group

Market Cap: US$12.6m

Through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.

Verici Dx

Market Cap: UK£9.5m

Together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States.

EXACT Therapeutics

Market Cap: NOK 126.5m

A clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT).

NovaBay Pharmaceuticals

Market Cap: US$12.6m

Does not have significant operations.

BLIS Technologies

Market Cap: NZ$21.7m

Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.